AstraZeneca Pharma India inaugurated a new corporate office in Mumbai on Friday, October 16. Spread across 25,600 sq ft, the office was inaugurated by Maharashtra Chief Minister Devendra Fadnavis, in the presence of senior government officials, diplomatic representatives and company leaders.
Fadnavis said Maharashtra has a strong and growing pharmaceutical and life-sciences ecosystem, and that AstraZeneca's decision to establish its India commercial office in Mumbai reflects confidence in the state's capabilities and its potential as an innovation hub.
Country President and Managing Director Praveen Rao Akkinepally said India is at an important stage in healthcare development, with a growing need for earlier diagnosis, innovative treatments and more equitable access to care.
Over the past three years, the company has introduced more than 25 new medicines and indications in India. It is running around 80 global clinical trials in the country and employs nearly 5,000 people across India.
The Mumbai office will support collaboration across oncology, biopharmaceuticals and rare diseases. The company said it is working with governments and industry partners to use artificial intelligence across prevention, awareness, diagnosis and treatment.
25,600 sq ft Mumbai office • Inaugurated by CM Devendra Fadnavis on Oct 16 • 25+ new medicines and indications in India in 3 years • Around 80 global clinical trials in India • Nearly 5,000 employees across India
Sources: ScanX; Medical Dialogues.